Skip to main content

Table 1 Demographic and clinical data for 101 patients related to over-expression of heparanase based on IHC staining

From: Expression of heparanase in soft tissue sarcomas of adults

Characteristic No. of patients out of entire group No. of patients with over-expressed heparanase, according to sub-groups (%) P value
Age <40 21 6 (28.5%) 0.65
40-59 21 11 (52.4%)
60-69 30 16 (53.3%)
>70 29 12 (43.3%)
Gender Male 58 25 (43.1%) 0.88
Female 43 20 (46.5%)
Pathological type Malignant fibrous histiocytoma 30 12 (40%) 0.87
Liposarcoma 16 8 (50%)
Leiomyosarcoma 13 6 (46.1%)
Angiosarcoma 4 1 (25%)
Chondrosarcoma 7 5 (71.4%)
Sinovial sarcoma 9 4 (44.4%)
NOS 22 9 (40.9%)
Grade Low 28 12 (42.8%) 0.44
Intermediate 6 2 (33.3%)
High 67 31 (46.2%)
Stage I 29 13 (44.8%) 0.55
II 7 1 (14.3%)
III 46 20 (43.4%)
IV 19 11 (57.9%)
Total 101 51 (50.5%)